Citadel Advisors’s CRH Medical Corporation CRHM Stock Holding History

Citadel Advisors’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,012	Closed	-$35K	–	10471
2019 Q4	$35K	Buy	+10,012	New	+$31.6K	﹤0.01%	8838
2019 Q1	–	Sell	-15,310	Closed	-$47K	–	10137
2018 Q4	$47K	Sell	15,310 -6,460	-30%	-$21.3K	﹤0.01%	8504
2018 Q3	$86K	Buy	21,770 +4,471	+26%	+$16.5K	﹤0.01%	8635
2018 Q2	$54K	Buy	+17,299	New	+$55.2K	﹤0.01%	8427
2018 Q1	–	Sell	-13,071	Closed	-$35K	–	9007
2017 Q4	$35K	Buy	+13,071	New	+$29.2K	﹤0.01%	7736
2017 Q3	–	Sell	-13,175	Closed	-$75K	–	8279
2017 Q2	$75K	Buy	+13,175	New	+$85.5K	﹤0.01%	6997

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

SCM

Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CRHM Position: Q1 2020 in Review

Citadel Advisors sold out of CRH Medical Corporation (CRHM) in Q1 2020, closing a stake of 10,012 shares — an estimated $35K sold.

Citadel Advisors first reported a position in CRHM in Q2 2017 and held it in 6 quarters. The position peaked at $86K in Q3 2018. 45 funds tracked by Wall St. Rank hold CRHM as of Q1 2020.

Citadel Advisors reported no remaining CRH Medical Corporation position as of Q1 2020 after selling out during the quarter.
Citadel Advisors sold 10,012 CRH Medical Corporation shares in Q1 2020, an estimated $35K.
Citadel Advisors first reported a position in CRH Medical Corporation in Q2 2017 and held it in 6 quarters.
Citadel Advisors's CRH Medical Corporation position peaked at $86K in Q3 2018.
45 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.